Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Zdravka Ognyanova Medarova, Ph.D.

Co-Author

This page shows the publications co-authored by Zdravka Medarova and Byung Hee Yoo.
Connection Strength

9.682
  1. MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer. Sci Rep. 2021 02 02; 11(1):2844.
    View in: PubMed
    Score: 0.919
  2. Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells. Sci Rep. 2020 02 06; 10(1):1970.
    View in: PubMed
    Score: 0.858
  3. MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer. PLoS One. 2019; 14(12):e0226356.
    View in: PubMed
    Score: 0.849
  4. RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy. Sci Rep. 2019 03 18; 9(1):4712.
    View in: PubMed
    Score: 0.806
  5. Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin. PLoS One. 2018; 13(7):e0201046.
    View in: PubMed
    Score: 0.770
  6. New Directions in the Study and Treatment of Metastatic Cancer. Front Oncol. 2018; 8:258.
    View in: PubMed
    Score: 0.769
  7. Guidelines for Rational Cancer Therapeutics. Front Oncol. 2017; 7:310.
    View in: PubMed
    Score: 0.739
  8. Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer. Sci Rep. 2017 03 21; 7:45060.
    View in: PubMed
    Score: 0.702
  9. In Vivo Detection of miRNA Expression in Tumors Using an Activatable Nanosensor. Mol Imaging Biol. 2016 Feb; 18(1):70-8.
    View in: PubMed
    Score: 0.649
  10. Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer. Cancer Res. 2015 Oct 15; 75(20):4407-15.
    View in: PubMed
    Score: 0.632
  11. Design of nanodrugs for miRNA targeting in tumor cells. J Biomed Nanotechnol. 2014 Jun; 10(6):1114-22.
    View in: PubMed
    Score: 0.578
  12. Detection of miRNA expression in intact cells using activatable sensor oligonucleotides. Chem Biol. 2014 Feb 20; 21(2):199-204.
    View in: PubMed
    Score: 0.564
  13. Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. Cancers (Basel). 2022 Mar 21; 14(6).
    View in: PubMed
    Score: 0.248
  14. Radiolabeling and PET-MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer. Cancer Nanotechnol. 2021; 12(1).
    View in: PubMed
    Score: 0.237
  15. Combination treatment with theranostic nanoparticles for glioblastoma sensitization to TMZ. Mol Imaging Biol. 2014 Oct; 16(5):680-9.
    View in: PubMed
    Score: 0.148
  16. Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model. Int J Cancer. 2013 Apr 15; 132(8):1860-7.
    View in: PubMed
    Score: 0.129
  17. Magnetic resonance imaging of intra-pancreatic ductal nanoparticle delivery to islet cells. Diabetes Metab Res Rev. 2017 07; 33(5).
    View in: PubMed
    Score: 0.044
  18. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer. Int J Cancer. 2016 08 01; 139(3):712-8.
    View in: PubMed
    Score: 0.041
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.